ConCallIQ
Go Pro

Healthcare Q4 FY26 results

13 companies · ₹18,654 Cr aggregate revenue · 19.5% average EBITDA margin

Companies

Ajanta Pharma · Q4 FY26 bullish high

Ajanta Pharma delivered a strong Q4 FY26 with revenue of ₹1,422 crore (+21% YoY) and PAT of ₹267 crore (+18% YoY).

Read analysis →
Artemis Medicare Services · Q4 FY26 bullish high

Artemis Medicare delivered a strong Q4 FY26 with consolidated revenue of INR 279 crore (+16.4% YoY) and PAT of INR 30 crore (+32.1% YoY), driven by higher patient volumes in hig...

Read analysis →
Emcure Pharmaceuticals · Q4 FY26 bullish high

Emcure delivered a strong Q4 FY26 with revenue of ₹2,470 crore (+16.7% YoY) and EBITDA margin expansion of 130 bps to 19.7%, driven by robust international growth (+25.7%) and o...

Read analysis →
Piramal Pharma · Q4 FY26 neutral medium

Piramal Pharma reported a transitional FY26 with revenue decline due to inventory destocking in a key on-patent commercial product, subdued biotech funding in H1, and intensifie...

Read analysis →
Ventive Hospitality · Q4 FY26 bullish high

Ventive Hospitality delivered a strong Q4 FY26 with consolidated revenue of ₹870 crore (+21% YoY) and EBITDA of ₹476 crore (+28% YoY), driven by pricing power in India (ADR +12%...

Read analysis →
RPG Life Sciences · Q4 FY26 bullish high

RPG Life Sciences delivered a strong Q4 FY26 with revenue of 176.9 cr (+23.6% YoY) and EBITDA of 45.2 cr (+48% YoY), driven by domestic formulation growth of 18.2% (1.8x IPM) an...

Read analysis →
Medi Assist Healthcare · Q4 FY26 bullish high

Medi Assist delivered a strong FY26 with operating revenue of ₹904.8 crore (+25.1% YoY) and EBITDA of ₹174.6 crore (19.3% margin).

Read analysis →
Raymond Lifestyle · Q4 FY26 bullish high

Raymond Lifestyle delivered a strong FY26 with total income of ₹7,034 crore (+11% YoY) and EBITDA of ₹804 crore (+23% YoY), marking the highest ever.

Read analysis →
Cipla · Q4 FY26 bullish high

Cipla delivered a strong Q4 FY26 with India business growing 15% YoY and North America revenue of $155M.

Read analysis →
Onesource Specialty Pharma · Q4 FY26 bullish high

Onesource Specialty Pharma delivered a strong Q4 FY26 recovery with revenue of ₹428.2 crore (up 47% QoQ) and EBITDA of ₹91.9 crore (up >5x QoQ), driven by the start of commercia...

Read analysis →
Mahindra Lifespace Developers · Q4 FY26 bullish medium

Mahindra Lifespace reported a strong Q4 FY26 with residential pre-sales of ₹1,633 crore and full-year PAT of ₹298 crore, a 5x jump YoY, driven by successful launches and IC leas...

Read analysis →
Aditya Birla Sun · Q4 FY26 neutral medium

Aditya Birla Sun Life AMC reported Q4 FY26 revenue of ₹458 crore (+6.8% YoY), but EBITDA fell to ₹222 crore (-4.7% YoY) and PAT dropped to ₹181 crore (-20.6% YoY) due to mark-to...

Read analysis →
Westlife Foodworld · Q4 FY26 bullish medium

Westlife Foodworld reported Q4 FY26 revenue of ₹660 crore, up 9% YoY, with same-store sales growth of 1.5% driven by mid-single-digit guest count growth.

Read analysis →